AKT1 and cancer: To date, growing evidence suggests that genistein has the ability to inhibit cancer cell proliferation and induce cell apoptosis through regulation of biological molecules, such as the estrogen or androgen receptor, protein-tyrosine kinase, NF-kappa B, Akt and MAPK pathways [14–17].